Parkinson's inhaler trial halted early: what happened?
Symptom relief
Terminated
This study tested an inhaler called Staccato Apomorphine (AZ-009) to quickly relieve 'OFF' episodes in people with Parkinson's disease—times when symptoms return between medication doses. The trial planned to include patients who had daily OFF episodes, but it was terminated earl…
Phase: PHASE2 • Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC